Search research articles
Contact Us
Filters
Showing results (1-10 of 101) with videos related to
Page
of 11
Sort By:
Wiener Klinische Wochenschrift
|
January 1, 1991
Recent developments in receptor binding radiopharmaceuticals
P Angelberger
Strahlentherapie. Sonderbande
|
January 1, 1975
[Production of ready-to-use technetium (Tc)-99m and Tc99m-labeled radiopharmaceuticals]
P Angelberger
Nuclear Medicine Communications
|
October 1, 1988
Imaging and kinetics studies with radiolabelled autologous low-density lipoproteins (LDL) in human atherosclerosis
H Sinzinger, P Angelberger
Nuklearmedizin. Nuclear Medicine
|
June 1, 1987
[Myocardial scintigraphy using cationic 99m Tc complexes]
R Dudczak, P Angelberger
Thrombosis and Haemostasis
|
June 30, 1981
Influence of incubation time and temperature on indium-111-oxide uptake by human platelets
H Sinzinger, P Angelberger, H Kolbe
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 1981
Platelet labeling with in-111 oxine: benefit of prostacyclin (PgI2)--addition for preparation and injection
H Sinzinger, P Angelberger, R Höfer
European Journal of Nuclear Medicine
|
October 1, 1979
Comparison of two different biliary agents in healthy subjects and in patients with liver disease
R Dudczak, K Kletter, P Angelberger, et al.
European Journal of Nuclear Medicine
|
January 1, 1986
Imaging of human atherosclerotic lesions using 123I-low-density lipoprotein
H Sinzinger, H Bergmann, J Kaliman, et al.
European Journal of Nuclear Medicine
|
January 1, 1991
Low density lipoprotein labelling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage
I Virgolini, P Angelberger, J O'Grady, et al.
Wiener Klinische Wochenschrift
|
February 3, 1984
[In vitro and in vivo studies using 111 indium oxine, 111 indium oxine sulfate and 99m Tc oxine in erythrocyte labeling]
S Reiter, P Angelberger, H Kolbe, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 101) with videos related to
Sort By:
Page
of 11
Wiener Klinische Wochenschrift
|
January 1, 1991
Recent developments in receptor binding radiopharmaceuticals
P Angelberger
Strahlentherapie. Sonderbande
|
January 1, 1975
[Production of ready-to-use technetium (Tc)-99m and Tc99m-labeled radiopharmaceuticals]
P Angelberger
Nuclear Medicine Communications
|
October 1, 1988
Imaging and kinetics studies with radiolabelled autologous low-density lipoproteins (LDL) in human atherosclerosis
H Sinzinger, P Angelberger
Nuklearmedizin. Nuclear Medicine
|
June 1, 1987
[Myocardial scintigraphy using cationic 99m Tc complexes]
R Dudczak, P Angelberger
Thrombosis and Haemostasis
|
June 30, 1981
Influence of incubation time and temperature on indium-111-oxide uptake by human platelets
H Sinzinger, P Angelberger, H Kolbe
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
March 1, 1981
Platelet labeling with in-111 oxine: benefit of prostacyclin (PgI2)--addition for preparation and injection
H Sinzinger, P Angelberger, R Höfer
European Journal of Nuclear Medicine
|
October 1, 1979
Comparison of two different biliary agents in healthy subjects and in patients with liver disease
R Dudczak, K Kletter, P Angelberger, et al.
European Journal of Nuclear Medicine
|
January 1, 1986
Imaging of human atherosclerotic lesions using 123I-low-density lipoprotein
H Sinzinger, H Bergmann, J Kaliman, et al.
European Journal of Nuclear Medicine
|
January 1, 1991
Low density lipoprotein labelling characterizes experimentally induced atherosclerotic lesions in rabbits in vivo as to presence of foam cells and endothelial coverage
I Virgolini, P Angelberger, J O'Grady, et al.
Wiener Klinische Wochenschrift
|
February 3, 1984
[In vitro and in vivo studies using 111 indium oxine, 111 indium oxine sulfate and 99m Tc oxine in erythrocyte labeling]
S Reiter, P Angelberger, H Kolbe, et al.
Page
of 11